4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005222
Chief Scientific Officer sold 100,000 shares at an average $67.60 ($6,759,576)
- Chief Scientific Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Option exercise | +50,000 | $6.55 | $327,500 | 50,679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Sale | −31,146 | $67.02 | $2,087,405 | 19,533 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Sale | −3,001 | $67.74 | $203,288 | 16,532 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Sale | −5,701 | $69.26 | $394,851 | 10,831 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Sale | −8,052 | $69.97 | $563,398 | 2,779 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Sale | −2,100 | $70.75 | $148,575 | 679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-20 | Option exercise | +50,000 | $6.55 | $327,500 | 50,679 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-20 | Sale | −20,394 | $66.84 | $1,363,135 | 30,285 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-20 | Sale | −24,945 | $67.39 | $1,681,044 | 5,340 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-20 | Sale | −4,661 | $68.20 | $317,880 | 679 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-19 | Option exercise · Stock Option (Right to Buy) | −50,000 | 350,000 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-01-20 | Option exercise · Stock Option (Right to Buy) | −50,000 | 300,000 | D | ||
| Open-market sales · 100,000 sh · avg $67.60 · $6,759,576 | |||||||
Loading xslF345X03/doc4a.xml…